"Tears" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The fluid secreted by the lacrimal glands. This fluid moistens the CONJUNCTIVA and CORNEA.
| Descriptor ID |
D013666
|
| MeSH Number(s) |
A12.200.882
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tears".
Below are MeSH descriptors whose meaning is more specific than "Tears".
This graph shows the total number of publications written about "Tears" by people in this website by year, and whether "Tears" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1997 | 4 | 1 | 5 |
| 1998 | 4 | 0 | 4 |
| 1999 | 3 | 2 | 5 |
| 2000 | 5 | 1 | 6 |
| 2001 | 3 | 0 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 2 | 2 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 6 | 2 | 8 |
| 2008 | 2 | 1 | 3 |
| 2009 | 3 | 2 | 5 |
| 2010 | 3 | 3 | 6 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 3 | 5 |
| 2014 | 1 | 0 | 1 |
| 2015 | 6 | 5 | 11 |
| 2016 | 1 | 1 | 2 |
| 2017 | 4 | 3 | 7 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 2 | 2 |
| 2020 | 5 | 5 | 10 |
| 2021 | 3 | 2 | 5 |
| 2022 | 1 | 5 | 6 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 3 | 4 |
| 2025 | 3 | 4 | 7 |
| 2026 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tears" by people in Profiles.
-
Investigating conjunctival immune pathways in Sj?gren and non-Sj?gren disease associated dry eye. Ocul Surf. 2026 Apr; 40:52-62.
-
A comprehensive review of tear fluid proteome alterations in dry eye disease: Insights into pathophysiology and biomarker potential. Ocul Surf. 2026 Apr; 40:71-85.
-
Comprehensive profiling of the human tear fluid miRNome using small RNA sequencing. Ocul Surf. 2026 Apr; 40:133-143.
-
Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease. Am J Ophthalmol. 2026 Apr; 284:216-225.
-
Delphi panel on neuromodulation as a treatment strategy for dry eye disease: Unlocking the potential of natural tear production. Ocul Surf. 2026 Jan; 39:34-40.
-
Corneal sensory nerve regulation of tear production through stimulation of transient receptor potential melastatin 8 (TRPM8) channel: A potential new approach for treating dry eye disease. Ocul Surf. 2025 Oct; 38:142-154.
-
Defining spaceflight associated dry eye syndrome (SADES): Mechanisms, complications, and countermeasures. Exp Eye Res. 2025 Sep; 258:110513.
-
Identification of a translatable animal model for dry eye disease using comparative analysis of tear proteins across species. Ocul Surf. 2025 Jul; 37:260-272.
-
Glands of Moll: history, current knowledge and their role in ocular surface homeostasis and disease. Prog Retin Eye Res. 2025 May; 106:101362.
-
Dessicating stress triggers and exacerbates experimental ocular Graft-versus-host-disease. Ocul Surf. 2025 Jul; 37:236-246.